News & Analysis as of August 21, 2025

Global Dealmaking

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

South & Southeast Asia M&A Report

Conyers on 4/14/2025

We are pleased to provide this twice-annual report summarising notable mergers and acquisitions activity in South and Southeast Asia, highlighting transactions over US$100 million in aggregate value. This edition features...more

Cross-Border M&A Opportunities Favor the Prepared

DarrowEverett LLP on 4/18/2024

Cross-border mergers and acquisitions (“M&A”) unlock growth, diversification, and a stronger global stance for businesses. These strategic moves enable firms from different nations to blend resources, making way into new...more

Market Opportunities for Cross-Border M&A in China Persist Despite Regulatory Changes and Trade Tensions

Skadden, Arps, Slate, Meagher & Flom LLP on 12/18/2023

After a multiyear low in 2022, China’s cross-border M&A activity experienced a slow recovery in 2023. Although outbound M&A deal value and volume remained lackluster in the first half of 2023, the market overall rebounded in...more

Spanish M&A resists market pressures in H1

White & Case LLP on 8/17/2023

Dealmakers across Europe were hampered by elevated core inflation rates and a darkening economic outlook in the first half of 2023. The constrained financing environment has put a check on dealmaking activity across the...more

European biotech enjoys a burst of dealmaking activity

White & Case LLP on 6/13/2023

European biotech just enjoyed its most abundant quarter in nearly two years in a tentative sign of a renaissance in the sector. There were 46 deals in Q1 2023, the second biggest year for deals in the region on Mergermarket...more

Q4 2022 Quarterly Corporate / M&A decisions updates

Hogan Lovells on 4/7/2023

Below is our Corporate / M&A decisions update covering decisions in the fourth quarter of 2022. This update is designed to highlight selected important M&A, corporate, and commercial court decisions on a quarterly basis....more

Global healthcare M&A delivers strong performance

White & Case LLP on 1/25/2023

Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 - Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022,...more

Renewables push drives M&A in Japan’s energy sector

White & Case LLP on 5/6/2022

Ambitious decarbonization targets and high investment returns are drawing interest from both local and international buyers - M&A in Japan’s energy and utilities sectors has reached a new peak in recent years, with 24 deals...more

8 Results

View per page

Page: of 1

Today's Popular Updates › Investment › Global Dealmaking

"My best business intelligence, in one easy email…"